Awareness of illness in schizophrenia and outpatient treatment adherence

The Journal of Nervous and Mental Disease
B J CuffelR R Owen

Abstract

We present a brief measure of awareness of illness in schizophrenia and test whether awareness is related to perceived need for and adherence to outpatient psychiatric treatment. A prospective design assessed treatment adherence, awareness of the signs and symptoms of schizophrenia, symptoms, neurocognitive status, and substance abuse at baseline and 6-month follow-up in 89 persons with schizophrenia. Results indicate that persons with greater awareness perceived greater need for outpatient treatment and evidenced better adherence to outpatient treatment when adherence and awareness were measured concurrently. Awareness was not related to adherence at 6-month follow-up. In addition, neurocognitive impairment was associated with lower overall adherence to treatment when reported by collaterals at baseline and 6-month follow-up. Neurocognitive impairment was, however, associated with higher self-reported adherence to medication, which suggests that neurocognitive status may bias adherence reporting in persons with schizophrenia.

References

Apr 1, 1976·Archives of General Psychiatry·W T CarpenterJ S Strauss
Jan 1, 1991·Schizophrenia Bulletin·X F AmadorJ M Gorman
Jan 1, 1989·The Journal of Nervous and Mental Disease·J P McEvoyL Roth
Jan 1, 1989·The Journal of Nervous and Mental Disease·J P McEvoyL Roth
Jan 1, 1989·Schizophrenia Bulletin·D GreenfeldM Mandelkern
May 1, 1986·Comprehensive Psychiatry·W H WilsonW Guy
Sep 1, 1973·The American Journal of Psychiatry·D A Treffert
Nov 1, 1994·Psychiatry·P LysakerJ Beam-Goulet
Oct 1, 1994·Archives of General Psychiatry·X F AmadorJ M Gorman
Sep 1, 1993·Hospital & Community Psychiatry·J P McEvoyL J Apperson
Jan 1, 1993·The Psychiatric Quarterly·X F Amador, D H Strauss
Jun 1, 1993·The American Journal of Psychiatry·X F AmadorJ M Gorman
Apr 1, 1996·Community Mental Health Journal·B J CuffelG Piccagli

❮ Previous
Next ❯

Citations

Nov 22, 2011·The Psychiatric Quarterly·Klára Látalová
Feb 6, 2004·Journal of Psychiatric Research·Thomas E SmithJoel F McClough
May 15, 2002·Psychiatry Research·Olli KampmanKlaus Lehtinen
Nov 5, 2002·Schizophrenia Research·Paul H LysakerMorris D Bell
Mar 22, 2003·Schizophrenia Research·Alisa R MintzDavid M Romney
Mar 22, 2003·European Psychiatry : the Journal of the Association of European Psychiatrists·O KampmanE Leinonen
Mar 2, 2005·AIDS Care·K K UldallUNKNOWN HIV/AIDS Treatment Adherence, Health Outcomes and Cost Study Group
May 19, 2006·Schizophrenia Bulletin·Dawn I VelliganAlexander L Miller
May 23, 2008·Schizophrenia Bulletin·Robyn Langdon, Philip Ward
Jan 19, 2002·Journal of Clinical Psychopharmacology·Thomas L PattersonDilip V Jeste
Feb 25, 2005·International Clinical Psychopharmacology·Craig GoodmanHenry Silver
Jul 29, 1998·The Journal of Nervous and Mental Disease·P H LysakerE Kaplan
Mar 6, 1999·The Journal of Nervous and Mental Disease·P H LysakerE Kaplan
Mar 30, 2002·The Journal of Nervous and Mental Disease·Paul H LysakerMorris D Bell
May 5, 2005·The Journal of Nervous and Mental Disease·Josephine G W S WongEric Y H Chen
Oct 7, 2005·The Journal of Nervous and Mental Disease·Eric B ElbogenRichard Van Dorn
May 6, 2004·The Journal of Nervous and Mental Disease·Florence LiraudHélène Verdoux
Oct 16, 2013·Journal of Clinical Psychopharmacology·Johan ReutforsRobert Bodén
Jan 1, 2014·The Journal of Nervous and Mental Disease·Kit Wa Sherry ChanYu Hai Eric Chen
Dec 17, 2008·The Journal of Nervous and Mental Disease·David RoePaul H Lysaker
Jun 8, 2006·The Australian and New Zealand Journal of Psychiatry·Hector W H TsangPatrick W Corrigan
Sep 24, 1999·Acta Psychiatrica Scandinavica·O Kampman, K Lehtinen
Oct 31, 2002·Psychiatry·Paul H LysakerDustin E Wright
Nov 7, 2000·PharmacoEconomics·E Lindström, K Bingefors
Oct 11, 2003·Journal of Affective Disorders·Edward D Sturman, Beth A Sproule
May 28, 2010·The British Journal of Psychiatry. Supplement·Tim J LambertMaxine X Patel
Jan 19, 2006·Advances in Therapy·Kem P KruegerBill Felkey
Jan 22, 2013·Comprehensive Psychiatry·Cinzia MingroneFilippo Bogetto
Dec 3, 2011·European Psychiatry : the Journal of the Association of European Psychiatrists·C BressiA C Altamura
Jun 23, 2009·European Psychiatry : the Journal of the Association of European Psychiatrists·M A F De HertR van Winkel
Oct 14, 2008·Psychiatry Research·Pierre-Michel Llorca

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.